Skip to main content
. Author manuscript; available in PMC: 2021 Jun 15.
Published in final edited form as: Cancer Immunol Res. 2020 Apr 7;8(7):952–965. doi: 10.1158/2326-6066.CIR-19-0159

Figure 5: PARP1 expression is associated with PD-L1 levels and the CIITA cascade.

Figure 5:

A-C, correlation of PARP1 mRNA levels with putative PARP1 gene copy number (A), disease free (B) and overall survival (C) of lung adenocarcinoma patients (TCGA data). D-G, enrichment analysis for the association of CIITA (D), MHC (E and F), and PD-L1 (G) levels with high and low levels of PARP1/2 mRNA expression in lung adenocarcinoma (TCGA data).